Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v4-EN | Version v1-EN | |
---|---|---|
Language | English | English |
Date Updated | 2021-05-20 | 2021-05-04 |
Drug Identification Number | 02042479 | 02042479 |
Brand name | MARVELON 28 | MARVELON 28 |
Common or Proper name | desogestrel and ethinyl estradiol tablets, | desogestrel and ethinyl estradiol tablets, |
Company Name | ORGANON CANADA INC. | ORGANON CANADA INC. |
Ingredients | DESOGESTREL ETHINYL ESTRADIOL | DESOGESTREL ETHINYL ESTRADIOL |
Strength(s) | 0.15MG 0.03MG | 0.15MG 0.03MG |
Dosage form(s) | TABLET | TABLET |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | 28 | 28' |
ATC code | G03AA | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | 2021-05-24 | 2021-05-24 |
Actual start date | ||
Estimated end date | 2021-06-28 | 2021-06-28 |
Actual end date | 2021-05-20 | |
Shortage status | Avoided shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Format MARVELON 0.150/0.03MG 21TAB remains available | Format MARVELON 0.150/0.03MG 21TAB remains available |
Health Canada comments |